Rosivo - Rosivo Inc - Biologic Implants Refined

Biologic Implants, Refined

FDA regulation, lengthy time to market and high cost of development delay the release of new Class III medical devices and Biologic therapies. Many indications exist in which Class II biomaterial therapies could provide improved outcomes while possessing a fast route to market and significantly reduced cost compared to Class III devices and Biologics. Rosivo Inc aims to develop biomaterial therapies to treat these indications.

About Us

Latest News

Cartesse by Rosivo: Winner of the 2018 Utah Innovation Awards Most Innovative Medical Device technology!
2018 Utah Innovation Awards has just announced Cartesse technology by Rosivo as a Finalist for Utah's most innovative medical device technology!
Rosivo Inc is a proud awardee of USTAR's Technology Acceleration Program grant
Rosivo Inc is a proud awardee of the Utah Technology Commercialization and Innovation Program
Rosivo Inc has joined the BioInnovations Gateway biotech incubator in South Salt Lake